Diabetes is a global health problem with over 199 million women living with the condition, a figure that is expected to rise to 313 million by 2040. In this issue, we explore the specific challenges that women with diabetes face and how technology is helping them manage their condition.

We also take a deep dive into investments in emerging ‘taboo tech’ which address unspoken needs in the medical space.

The taboo medtech sector is set to experience growth due to growing discussion around topics that were previously ignored such as women’s health, sex and medical cannabis use.

Elsewhere in this issue, we look at what China’s domestic agenda means for foreign medical device developers and how the field of renal denervation therapy is evolving.

Keep reading for the latest and most significant medical device industry news, data and insights from GlobalData journalists and analysts.

Catherine Longworth, Editor